Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
- Vera A. Bittner
- , Michael Szarek
- , Philip E. Aylward
- , ODYSSEY OUTCOMES Committees and Investigators
- , Aldis Strelnieks (Member of the Working Group)
Research output: Contribution to journal › Article › peer-review
485
Citations
(Scopus)